Page 17 - Bharat Biotech

A new vaccine regime

Govt conducts welcome course correction

Govt fast-tracks Covid-19 fight, to start vaccination for 18+ from May 1

States allowed to procure directly from manufacturers; open market supply permitted

Serum, Bharat Biotech to get suppliers' credit for 300 mn Covid-19 doses

Govt okays Rs 4,500 cr upfront payment for 300 mn doses

Expanding vaccine supply

Some good moves but freer pricing needed

Govt push to step up Covid-19 vaccine output 10 times by September

Bharat Biotech and 3 PSEs to ramp up Covaxin production capacity

India to increase Covaxin production to 100 mn doses per month by Sept

Currently, 10 mn doses of the indigenous coronavirus vaccine are being produced every month, says govt

Centre clears Mumbai's Haffkine to make Covaxin vaccine as cases rise

In a major step to ramp up vaccine production amid the Covid-19 second wave, the Centre has approved production of Corona vaccines from the Maharashtra government-owned Haffkine Institute in Mumbai

Haffkine Institute gets govt's approval to produce Bharat Biotech's Covaxin

Last month, Uddhav Thackeray had sought central nod to manufacture Bharat Biotech's Covaxin at Haffkine Institute

Shortage of key chemical hits Bharat Biotech's Covaxin ramp-up plans

Bharat Biotech is trying to ramp up capacities of Covaxin to 12 million doses per month by July, from the current 5 million doses per month

Covid-19 vaccine Sputnik V gets DCGI nod; may be available by May

Russian Covid-19 vaccine granted restricted emergency-use authorisation in India

Covid-19 vaccination sites drop to half in India amid shortage of doses

Number of locations down from 120,000 to 60,000 from April 3 to 7

Serum Institute, Bharat Biotech to speed up Covid-19 vaccine production

This comes after govt panel visits facilities of SII and Bharat Biotech

Govt's expert panel allows clinical trials for third dose of Covaxin

The expert panel of India's drug regulator, DCGI, has permitted Bharat Biotech to give a third dose of Covaxin to a few volunteers in its clinical trials of the Covid-19 vaccine, sources said

Brazil: Covaxin manufacturing facility fails to meet CGMP standards

Covaxin has demonstrated an interim vaccine efficacy of 81 per cent in the Phase 3 clinical trials

Supply chain threats

Vaccine nationalism shows how the pandemic has stressed trade

Bharat Biotech, CSIR collaborate to make raw material for vaccines

India now imports adjuvants and other chemicals for vaccine manufacturing

At $2.06 per dose, India pays the least for AstraZeneca Covid-19 vaccine

The price paid by different governments for a vaccine dose - including for the same vaccine - varies across countries, Unicef data shows

SII, Bharat Bio seek central fund injection to ramp up vaccine production

SII, Bharat Biotech want to increase production to meet domestic, foreign demand

Covaxin manufacturing may get a booster shot as demand for vaccines grows

Bharat Biotech also has another site at Bengaluru that is currently making vaccines other than Covaxin

Supply slipping, Centre to speed up Covid-19 vaccine delivery to states

Vaccine makers asked to send more doses to central government on priority